Obesity and Endogenous Oxalate Synthesis
Study Description
“Obesity and Endogenous Oxalate Synthesis”
The goal of this proposal is to determine the contribution and significance of obesity to urinary oxalate excretion and thus calcium oxalate kidney stone disease. Successful completion of the study will provide insight into the link between obesity and kidney stone disease and should identify future strategies to treat this disease.
Location
Methods
No pharmaceutical medication involved
Patients and healthy individuals accepted
Normal Individuals
Stage I: Controlled Dietary Study Phase II: Glycolate Phase III: Vitamin C Participants that agree,will undergo MRI to evaluate fatty liver
Calcium Oxalate Kidney Stone Formers
Stage I: Controlled Dietary Study Phase II: Glycolate Phase III: Vitamin C Participants that agree,will undergo MRI to evaluate fatty liver
Type 2 Diabetes
Stage I: Controlled Dietary Study Phase II: Glycolate Phase III: Vitamin C Participants that agree,will undergo MRI to evaluate fatty liver
Type 2 diabetic kidney stone formers
Stage I: Controlled Dietary Study Phase II: Glycolate Phase III: Vitamin C Participants that agree,will undergo MRI to evaluate fatty liver
Additional Information
Official Study Title
Obesity and Endogenous Oxalate Synthesis
Clinical Trial ID
NCT03808090
ParticipAid ID
bW6pXa
